Andrew Guggenhime Vaxcyte, Inc. (PCVX) insider trading activity

Andrew Guggenhime is PRESIDENT AND CFO of Vaxcyte, Inc.. Currently has a direct ownership of 131,950 shares of PCVX, which is worth approximately $3.96 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 4,649 shares (Common Stock) at a price of $26.38 per share, resulting in proceeds of $122,641. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

0% 3M change

36.42% 12M change

Total Value Held $3.96 Million

ANDREW GUGGENHIME Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 02 2022	SELL Payment of exercise price or tax liability	$122,641 $26.38 p/Share	4,649 Reduced 11.02%	37,538 Common Stock
Aug 29 2022	SELL Open market or private sale	$494,284 $28.0 p/Share	17,653 Reduced 29.5%	42,187 Common Stock
Aug 29 2022	BUY Exercise of conversion of derivative security	$94,444 $5.35 p/Share	17,653 Added 22.78%	59,840 Common Stock
Aug 26 2022	SELL Open market or private sale	$36,260 $28.0 p/Share	1,295 Reduced 2.98%	42,187 Common Stock
Aug 26 2022	BUY Exercise of conversion of derivative security	$6,928 $5.35 p/Share	1,295 Added 2.89%	43,482 Common Stock
Aug 25 2022	SELL Open market or private sale	$477,456 $28.0 p/Share	17,052 Reduced 28.79%	42,187 Common Stock
Aug 25 2022	BUY Exercise of conversion of derivative security	$91,228 $5.35 p/Share	17,052 Added 22.35%	59,239 Common Stock
Aug 18 2022	SELL Open market or private sale	$79,081 $25.51 p/Share	3,100 Reduced 6.85%	42,187 Common Stock
Aug 18 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.41%	45,287 Common Stock
Jul 18 2022	SELL Open market or private sale	$76,787 $24.77 p/Share	3,100 Reduced 6.85%	42,187 Common Stock
Jul 18 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.41%	45,287 Common Stock
Jul 08 2022	SELL Open market or private sale	$74,400 $24.0 p/Share	3,100 Reduced 6.85%	42,187 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.41%	45,287 Common Stock
May 18 2022	SELL Open market or private sale	$76,694 $24.74 p/Share	3,100 Reduced 6.85%	42,187 Common Stock
May 18 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.41%	45,287 Common Stock
Apr 18 2022	SELL Open market or private sale	$74,555 $24.05 p/Share	3,100 Reduced 7.09%	40,625 Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.62%	43,725 Common Stock
Mar 18 2022	SELL Open market or private sale	$81,003 $26.13 p/Share	3,100 Reduced 7.09%	40,625 Common Stock
Mar 18 2022	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 6.62%	43,725 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	37,500 Added 48.0%	40,625 Common Stock
Mar 01 2022	SELL Open market or private sale	$148,800 $24.0 p/Share	6,200 Reduced 66.49%	3,125 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$33,170 $5.35 p/Share	6,200 Added 39.94%	9,325 Common Stock
Dec 23 2021	SELL Open market or private sale	$74,400 $24.0 p/Share	3,100 Reduced 49.8%	3,125 Common Stock
Dec 23 2021	BUY Exercise of conversion of derivative security	$16,585 $5.35 p/Share	3,100 Added 33.24%	6,225 Common Stock
Nov 18 2021	SELL Open market or private sale	$77,035 $24.85 p/Share	3,100 Reduced 49.8%	3,125 Common Stock

Also insider at

MTCR

Metacrine, Inc. Healthcare

Director

CRBU

Caribou Biosciences, Inc. Healthcare

Director

Andrew Guggenhime

PRESIDENT AND CFO

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account